Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-23 Sale |
2020-11-25 4:02 pm |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
35,321 | $18.6 | $657,020 | 75,695 (Direct) |
View |
| 2020-09-16 Purchase |
2020-09-17 09:42 am |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
2,550 | $5.6967 | $14,527 | 450,311 (Direct) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:17 pm |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
6,993 | $1.43 | $10,000 | 13,369 (Direct) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:16 pm |
Cardiff Oncology Inc. | CRDF | Markin Rodney S Director |
20,979 | $1.43 | $30,000 | 28,160 (Indirect) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:16 pm |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
6,993 | $1.43 | $10,000 | 9,260 (Direct) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:16 pm |
Cardiff Oncology Inc. | CRDF | JACOB GARY S Director |
17,483 | $1.43 | $25,001 | 19,552 (Direct) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:16 pm |
Cardiff Oncology Inc. | CRDF | White Lale Director |
69,930 | $1.43 | $100,000 | 69,930 (Indirect) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:15 pm |
Cardiff Oncology Inc. | CRDF | Armitage James O Director |
10,490 | $1.43 | $15,001 | 10,490 (Direct) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:15 pm |
Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Director |
13,986 | $1.43 | $20,000 | 18,875 (Direct) |
View |
| 2020-05-11 Purchase |
2020-05-13 4:16 pm |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
447,761 | $1.34 | $600,000 | 447,761 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-23 Exercise |
2020-11-25 4:02 pm |
N/A 2029-06-20 |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
35,321 | $2.48 | 75,695 (Direct) |
View |
Ownership |
2020-10-02 4:30 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 3,290,000 (Indirect) |
View |
Ownership |
2020-06-22 7:36 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO |
0 | $0 | 242,285 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:17 pm |
2021-06-17 2030-06-17 |
Cardiff Oncology Inc. | CRDF | PACE GARY W Director |
28,858 | $0 | 40,774 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:17 pm |
2021-06-17 2030-06-17 |
Cardiff Oncology Inc. | CRDF | Armitage James O Director |
28,858 | $0 | 40,774 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:16 pm |
2021-06-17 2030-06-17 |
Cardiff Oncology Inc. | CRDF | White Lale Director |
28,858 | $0 | 40,774 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:16 pm |
2021-06-17 2030-06-17 |
Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director |
28,858 | $0 | 76,517 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:16 pm |
2021-06-17 2030-06-17 |
Cardiff Oncology Inc. | CRDF | JACOB GARY S Director |
28,858 | $0 | 76,106 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:15 pm |
N/A 2030-06-17 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
221,241 | $0 | 380,200 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:15 pm |
2021-06-17 2030-06-17 |
Cardiff Oncology Inc. | CRDF | Markin Rodney S Director |
28,858 | $0 | 75,827 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:15 pm |
N/A 2030-06-17 |
Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Executive Chairman |
173,145 | $0 | 477,870 (Direct) |
View |